| Caption | CU Medicine is the first to discover a series of good bacteria missing in the gut of COVID-19 patients. The research team confirmed this discovery with a large number of healthy subjects and COVID-19 patients. Using metagenomics and big data analysis, the research team has successfully developed a probiotic formula that aims to target gut dysbiosis. Prof. Francis CHAN, Dean of CU Medicine and Director of the Centre for Gut Microbiota Research at CUHK and Prof. Siew NG (left), Associate Director. |
| Source | The Faculty of Medicine of The Chinese University of Hong Kong |
| Other pictures |
|
| Download | |
| Related Press Releases Links |
港中大全球首证新冠患者肠道微生态现失衡状况 CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19 |